Summary

<!--[if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-fareast-language:JA;} </style> <![endif]-->

Ronald Sosnowski holds a doctoral degree in Biochemistry from The Johns Hopkins University and has 25 years experience in biotechnology and biotech start-ups. He has focused on the analysis of genetics variants for molecular diagnostics, including identification of pathogenic microbes and for human identification in the field of forensics.

Dr. Sosnowski has been on the starting team of a publicly held company (Nanogen) and a venture funded start-up Adnavance Technologies, developing new methods and products for detection of pathogens. Most recently he is the co-founder of a company developing new technology for DNA forensics, Casework Genetics, LLC.

Work History

Work History
2009 - Present

Senior Scientific Advisor

Casework Genetics LLC

Education

Education
1987

Ph.D.

Johns Hopkins University